Ligand Discovery for the Alanine-Serine-Cysteine Transporter (ASCT2, SLC1A5) from Homology Modeling and Virtual Screening
Open accessThe DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
The Alanine-Serine-Cysteine transporter ASCT2 (SLC1A5) is a membrane protein that transports neutral amino acids into cells in exchange for outward movement of intracellular amino acids. ASCT2 is highly expressed in peripheral tissues such as the lung and intestines where it contributes to the homeostasis of intracellular concentrations of neutral amino acids. ASCT2 also plays an important role in the development of a variety of cancers such as melanoma by transporting amino acid nutrients such as glutamine into the proliferating tumors. Therefore, ASCT2 is a key drug target with potentially great pharmacological importance. Here, we identify seven ASCT2 ligands by computational modeling and experimental testing. In particular, we construct homology models based on crystallographic structures of the aspartate transporter GltPh in two different conformations. Optimization of the models' binding sites for protein-ligand complementarity reveals new putative pockets that can be targeted via structure-based drug design. Virtual screening of drugs, metabolites, fragments-like, and lead-like molecules from the ZINC database, followed by experimental testing of 14 top hits with functional measurements using electrophysiological methods reveals seven ligands, including five activators and two inhibitors. For example, aminooxetane-3-carboxylate is a more efficient activator than any other known ASCT2 natural or unnatural substrate. Furthermore, two of the hits inhibited ASCT2 mediated glutamine uptake and proliferation of a melanoma cancer cell line. Our results improve our understanding of how substrate specificity is determined in amino acid transporters, as well as provide novel scaffolds for developing chemical tools targeting ASCT2, an emerging therapeutic target for cancer and neurological disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
ZINC − A Free Database of Commercially Available Compounds for Virtual Screening
Irwin, J. J., & Shoichet, B. K. (2005) · Journal of Chemical Information and Modeling · doi:10.1021/ci049714+ · Cited by 4,058 · cited 6×
“(iii) The ZINC Fragment Now set that included 575,000 compounds with molecular weight (mwt) of 250 Dalton or lower, five or fewer rotatable bonds (rot), and xlogP value of 3.5 or lower, where xlogP is the octanol/water partition coefficient (logP) calculated by an atom additive method. iv) The ZINC Leads Now set that…”
BackgroundMethodInfluentialDirectory of useful decoys, enhanced (DUD-E): better ligands and decoys for better benchmarking.
Mysinger, M. M., Carchia, M., Irwin, J. J., & Shoichet, B. K. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm300687e · Cited by 2,412
Atomic-level characterization of the structural dynamics of proteins
Shaw, D. E., Maragakis, P., Lindorff-Larsen, K., Piana, S., Dror, R. O., Eastwood, M. P., Bank, J. A., Jumper, J. M., Salmon, J. K., Shan, Y., et al. (2010) · Science · doi:10.1126/science.1187409 · Cited by 1,923
Benchmarking sets for molecular docking.
Huang, N., Shoichet, B. K., & Irwin, J. J. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm0608356 · Cited by 1,318 · cited 1×
“ligands correctly predicted (y-axis) within the top ranked subset of all database compounds (xaxis on logarithmic scale) (Fig 2) [28,29,54].”
BackgroundPolypharmacology: Challenges and Opportunities in Drug Discovery: Miniperspective
Anighoro, A., Bajorath, J., & Rastelli, G. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm5006463 · Cited by 1,131
Targeting ASCT2‐mediated glutamine uptake blocks prostate cancer growth and tumour development
Wang, Q., Hardie, R., Hoy, A. J., van Geldermalsen, M., Gao, D., Fazli, L., Sadowski, M. C., Balaban, S., Schreuder, M., Nagarajah, R., et al. (2015) · The Journal of Pathology · doi:10.1002/path.4518 · Cited by 338 · cited 1×
“ASCT2 expression levels are increased in various types of cancer, including glioblastoma multiforme (GBM) [2], neuroblastoma [3], lung cancer [4], prostate cancer [5] and melanoma [6].”
BackgroundSelf-citationThe SLC1 high-affinity glutamate and neutral amino acid transporter family
Kanai, Y., Clémençon, B., Simonin, A., Leuenberger, M., Lochner, M., Weisstanner, M., & Hediger, M. A. (2013) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2013.01.001 · Cited by 329 · cited 2×
“, eight) with the human SLC1 family, as well as a conserved binding site; therefore the GltPh structure is the most suitable template for generating homology models of the SLC1 members [1,10,12].”
Background
Research works printed but not linked: 54
- BC Fuchs, 2005, Amino acid transporters ASCT2 and LAT1 in cancer: partners in crime?, Semin Cancer Biol, 15, 254, 10.1016/j.semcancer.2005.04.005 · DOI · Paper page
- P Ren, 2015, ATF4 and N-Myc coordinate glutamine metabolism in MYCN-amplified neuroblastoma cells through ASCT2 activation, J Pathol, 235, 90, 10.1002/path.4429 · DOI · Paper page
- M Hassanein, 2013, SLC1A5 mediates glutamine transport required for lung cancer cell growth and survival, Clin Cancer Res, 19, 560, 10.1158/1078-0432.CCR-12-2334 · DOI · Paper page
- Q Wang, 2014, Targeting glutamine transport to suppress melanoma cell growth, Int J Cancer, 135, 1060, 10.1002/ijc.28749 · DOI · Paper page
- P Nicklin, 2009, Bidirectional transport of amino acids regulates mTOR and autophagy, Cell, 136, 521, 10.1016/j.cell.2008.11.044 · DOI · Paper page
- Q Wang, 2013, Targeting amino acid transport in metastatic castration-resistant prostate cancer: effects on cell cycle, cell growth, and tumor development, J Natl Cancer Inst, 105, 1463, 10.1093/jnci/djt241 · DOI · Paper page
- A Schlessinger, 2013, Molecular Modeling and Ligand Docking for Solute Carrier (SLC) Transporters, Curr Top Med Chem, 13, 843, 10.2174/1568026611313070007 · DOI
- D Yernool, 2004, Structure of a glutamate transporter homologue from Pyrococcus horikoshii, Nature, 431, 811, 10.1038/nature03018 · DOI · Paper page
- O Boudker, 2007, Coupling substrate and ion binding to extracellular gate of a sodium-dependent aspartate transporter, Nature, 445, 387, 10.1038/nature05455 · DOI · Paper page
- A Schlessinger, 2013, SLC Classification: An Update, Clin Pharmacol Ther, 94, 19, 10.1038/clpt.2013.73 · DOI · Paper page
- S Qu, 2008, Substrates and non-transportable analogues induce structural rearrangements at the extracellular entrance of the glial glutamate transporter GLT-1/EAAT2, J Biol Chem, 283, 26391, 10.1074/jbc.M802401200 · doi:10.1074/jbc.m802401200
- T Albers, 2012, Defining substrate and blocker activity of alanine-serine-cysteine transporter 2 (ASCT2) Ligands with Novel Serine Analogs, Molecular Pharmacology, 81, 356, 10.1124/mol.111.075648 · DOI
- AJ Scopelliti, 2013, Molecular determinants for functional differences between alanine-serine-cysteine transporter 1 and other glutamate transporter family members, J Biol Chem, 288, 8250, 10.1074/jbc.M112.441022 · DOI
- ER Georgieva, 2013, Conformational ensemble of the sodium-coupled aspartate transporter, Nat Struct Mol Biol, 20, 215, 10.1038/nsmb.2494 · DOI
- S Stolzenberg, 2012, Structural intermediates in a model of the substrate translocation path of the bacterial glutamate transporter homologue GltPh, J Phys Chem B, 116, 5372, 10.1021/jp301726s · DOI
- TJ Crisman, 2009, Inward-facing conformation of glutamate transporters as revealed by their inverted-topology structural repeats, Proc Natl Acad Sci U S A, 106, 20752, 10.1073/pnas.0908570106 · DOI · Paper page
- O Jardetzky, 1966, Simple allosteric model for membrane pumps, Nature, 211, 969, 10.1038/211969a0 · DOI · Paper page
- N Reyes, 2009, Transport mechanism of a bacterial homologue of glutamate transporters, Nature, 462, 880, 10.1038/nature08616 · DOI · Paper page
- J Carlsson, 2011, Ligand discovery from a dopamine D3 receptor homology model and crystal structure, Nat Chem Biol, 7, 769, 10.1038/nchembio.662 · DOI · Paper page
- EG Geier, 2013, Structure-based ligand discovery for the Large-neutral Amino Acid Transporter 1, LAT-1, Proc Natl Acad Sci U S A, 110, 5480, 10.1073/pnas.1218165110 · DOI · Paper page
- A Schlessinger, 2011, Structure-based discovery of prescription drugs that interact with the norepinephrine transporter, NET, Proc Natl Acad Sci U S A, 108, 15810, 10.1073/pnas.1106030108 · DOI · Paper page
- PM Ung, 2015, DFGmodel: predicting protein kinase structures in inactive states for structure-based discovery of type-II inhibitors, ACS Chem Biol, 10, 269, 10.1021/cb500696t · DOI
- A Sali, 1993, Comparative protein modelling by satisfaction of spatial restraints, J Mol Biol, 234, 779, 10.1006/jmbi.1993.1626 · DOI · Paper page
- GG Krivov, 2009, Improved prediction of protein side-chain conformations with SCWRL4, Proteins, 77, 778, 10.1002/prot.22488 · DOI · Paper page
- B Hess, 2008, GROMACS 4: Algorithms for Highly Efficient, Load-Balanced, and Scalable Molecular Simulation, Journal of Chemical Theory and Computation, 4, 435, 10.1021/ct700301q · DOI · Paper page
- H Fan, 2009, Molecular docking screens using comparative models of proteins, J Chem Inf Model, 49, 2512, 10.1021/ci9003706 · DOI · Paper page
- M Kanehisa, 2000, KEGG: kyoto encyclopedia of genes and genomes, Nucleic Acids Res, 28, 27, 10.1093/nar/28.1.27 · DOI · Paper page
- M Kanehisa, 2014, Data, information, knowledge and principle: back to metabolism in KEGG, Nucleic Acids Res, 42, D199, 10.1093/nar/gkt1076 · DOI · Paper page
- ID Kuntz, 1992, Structure-based strategies for drug design and discovery, Science, 257, 1078, 10.1126/science.257.5073.1078 · DOI · Paper page
- BK Shoichet, 2004, Virtual screening of chemical libraries, Nature, 432, 862, 10.1038/nature03197 · DOI · Paper page
- A Broer, 2000, Neutral amino acid transporter ASCT2 displays substrate-induced Na+ exchange and a substrate-gated anion conductance, Biochemical Journal, 346, 705, 10.1042/bj3460705 · doi:10.1042/bj3460705 · Paper page
- C Grewer, 2004, New inhibitors for the neutral amino acid transporter ASCT2 reveal its Na+-dependent anion leak, J Physiol, 557, 747, 10.1113/jphysiol.2004.062521 · DOI · Paper page
- C Grewer, 2004, New inhibitors for the neutral amino acid transporter ASCT2 reveal its Na+-dependent anion leak, The Journal of physiology, 557, 747, 10.1113/jphysiol.2004.062521 · DOI · Paper page
- N Watzke, 2001, The anion conductance of the glutamate transporter EAAC1 depends on the direction of glutamate transport, FEBS Lett, 503, 121, 10.1016/S0014-5793(01)02715-6 · doi:10.1016/s0014-5793(01)02715-6
- RJ Bridges, 2005, The excitatory amino acid transporters: pharmacological insights on substrate and inhibitor specificity of the EAAT subtypes, Pharmacol Ther, 107, 271, 10.1016/j.pharmthera.2005.01.002 · DOI
- CB Zander, 2013, Voltage-dependent processes in the electroneutral amino acid exchanger ASCT2, J Gen Physiol, 141, 659, 10.1085/jgp.201210948 · doi:10.1085/jgp.201210948
- K Muller, 2007, Fluorine in pharmaceuticals: looking beyond intuition, Science, 317, 1881, 10.1126/science.1131943 · DOI · Paper page
- MJ Zamek-Gliszczynski, 2012, Highlights from the international transporter consortium second workshop, Clinical pharmacology and therapeutics, 92, 553, 10.1038/clpt.2012.126 · DOI · Paper page
- K Traynor, 2013, Canagliflozin approved for type 2 diabetes, Am J Health Syst Pharm, 70, 834, 10.2146/news130035 · doi:10.2146/news130035
- J Pei, 2008, PROMALS3D: a tool for multiple protein sequence and structure alignments, Nucleic acids research, 36, 2295, 10.1093/nar/gkn072 · DOI · Paper page
- MY Shen, 2006, Statistical potential for assessment and prediction of protein structures, Protein Sci, 15, 2507, 10.1110/ps.062416606 · DOI · Paper page
- D Eramian, 2008, How well can the accuracy of comparative protein structure models be predicted?, Protein Sci, 17, 1881, 10.1110/ps.036061.108 · DOI · Paper page
- K Lindorff-Larsen, 2010, Improved side-chain torsion potentials for the Amber ff99SB protein force field, Proteins, 78, 1950, 10.1002/prot.22711 · DOI · Paper page
- B Hess, 2007, P-LINCS: A Parallel Linear Constraint Solver for Molecular Simulation, J Chem Theory Comput, 4, 116, 10.1021/ct700200b · DOI · Paper page
- RG Coleman, 2013, Ligand pose and orientational sampling in molecular docking, PLoS One, 8, e75992, 10.1371/journal.pone.0075992 · DOI · Paper page
- A Schlessinger, 2011, Structure-based discovery of prescription drugs that interact with the norepinephrine transporter, NET, Proc Natl Acad Sci U S A, 108, 15810, 10.1073/pnas.1106030108 · DOI · Paper page
- A Schlessinger, 2012, High Selectivity of the gamma-Aminobutyric Acid Transporter 2 (GAT-2, SLC6A13) Revealed by Structure-based Approach, Journal of Biological Chemistry, 287, 37745, 10.1074/jbc.M112.388157 · DOI
- R Kekuda, 1996, Cloning of the sodium-dependent, broad-scope, neutral amino acid transporter Bo from a human placental choriocarcinoma cell line, J Biol Chem, 271, 18657, 10.1074/jbc.271.31.18657 · DOI · Paper page
- 2010, The Universal Protein Resource (UniProt) in 2010, Nucleic Acids Res, 38, D142, 10.1093/nar/gkp846 · DOI · Paper page
- M McGann, 2011, FRED pose prediction and virtual screening accuracy, J Chem Inf Model, 51, 578, 10.1021/ci100436p · DOI · Paper page
- RA Carr, 2005, Fragment-based lead discovery: leads by design, Drug Discov Today, 10, 987, 10.1016/S1359-6446(05)03511-7 · DOI · Paper page
- A Broer, 1999, The astroglial ASCT2 amino acid transporter as a mediator of glutamine efflux, J Neurochem, 73, 2184, 10.1046/j.1471-4159.1999.02184.x · DOI · Paper page
- N Watzke, 2001, Early intermediates in the transport cycle of the neuronal excitatory amino acid carrier EAAC1, J Gen Physiol, 117, 547, 10.1085/jgp.117.6.547 · DOI
- Q Wang, 2011, Androgen receptor and nutrient signaling pathways coordinate the demand for increased amino acid transport during prostate cancer progression, Cancer Res, 71, 7525, 10.1158/0008-5472.CAN-11-1821 · DOI · Paper page
Cited by
From Krebs to clinic: glutamine metabolism to cancer therapy
Altman, B. J., Stine, Z. E., & Dang, C. V. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2016.71 · Cited by 2,119
Glutamine transporters in mammalian cells and their functions in physiology and cancer
Bhutia, Y. D., & Ganapathy, V. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2015.12.017 · Cited by 325
Docking Screens for Novel Ligands Conferring New Biology: Miniperspective
Irwin, J. J., & Shoichet, B. K. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b02008 · Cited by 277
The Human SLC1A5 (ASCT2) Amino Acid Transporter: From Function to Structure and Role in Cell Biology
Scalise, M., Pochini, L., Console, L., Losso, M. A., & Indiveri, C. (2018) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2018.00096 · Cited by 265
Glutamine Transport and Mitochondrial Metabolism in Cancer Cell Growth
Scalise, M., Pochini, L., Galluccio, M., Console, L., & Indiveri, C. (2017) · Frontiers in Oncology · doi:10.3389/fonc.2017.00306 · Cited by 183
“The well-documented overexpression of some membrane transporters, above described (see Glutamine Supply to Cancer Cells; Table 1), boosted the research of potent and specific inhibitors; in particular, several reports dealt with the identification of inhibitors for ASCT2 (91) and LAT1 (92) via bioinformatics.”
Background
Metadata
- Authors
- Colas, C., Grewer, C., Otte, N. J., Gameiro, A., Albers, T., Singh, K., Shere, H., Bonomi, M., Holst, J., & Schlessinger, A.
- Venue
- PLOS Computational Biology
- Publisher
- Public Library of Science (PLoS)
- Published
- 2015-10-07
- Volume
- 11
- Issue
- 10
- Pages
- e1004477
- ISSN
- 1553-734X (ISSN-L)
- 1553-7358
- OpenAlex
- W1832385088
- Cited by
- 67
- References
- 7
- FWCI
- 3.88
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Ligand Discovery for the Alanine-Serine-Cysteine Transporter (ASCT2, SLC1A5) from Homology Modeling and Virtual Screening. https://app.cochat.ai/papers/10.1371/journal.pcbi.1004477
- The paper
- Colas, C., Grewer, C., Otte, N. J., Gameiro, A., Albers, T., Singh, K., Shere, H., Bonomi, M., Holst, J., & Schlessinger, A. (2015). Ligand Discovery for the Alanine-Serine-Cysteine Transporter (ASCT2, SLC1A5) from Homology Modeling and Virtual Screening. PLOS Computational Biology. https://doi.org/10.1371/journal.pcbi.1004477
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.